Cellectar Biosciences Inc (NASDAQ: CLRB) is 15.52% higher on its value in year-to-date trading and has touched a low of $0.22 and a high of $4.45 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CLRB stock was last observed hovering at around $0.32 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.35, the stock is -29.92% and -73.66% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.62 million and changing 6.31% at the moment leaves the stock -85.25% off its SMA200. CLRB registered -87.80% loss for a year compared to 6-month loss of -85.55%. The firm has a 50-day simple moving average (SMA 50) of $1.3118 and a 200-day simple moving average (SMA200) of $2.3425.
The stock witnessed a -76.34% gain in the last 1 month and extending the period to 3 months gives it a -84.01%, and is 12.58% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.61% over the week and 14.16% over the month.
Cellectar Biosciences Inc (CLRB) has around 23 employees, a market worth around $15.15M and $0.00M in sales. Distance from 52-week low is 54.20% and -92.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-295.11%).
The EPS is expected to grow by 48.15% this year.
Cellectar Biosciences Inc (CLRB) Top Institutional Holders
39.0 institutions hold shares in Cellectar Biosciences Inc (CLRB), with institutional investors hold 35.56% of the company’s shares. The shares outstanding are 40.57M, and float is at 40.04M with Short Float at 6.98%. Institutions hold 34.55% of the Float.
Cellectar Biosciences Inc (CLRB) Insider Activity
#####
